Nuvo Pharmaceuticals Inc. (MRVFF)
| Previous Close | 0.6039 |
| Open | 0.4770 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.4770 - 0.4770 |
| 52 Week Range | 0.4200 - 1.2500 |
| Volume | |
| Avg. Volume | 2,082 |
| Market Cap | 5.635M |
| Beta (5Y Monthly) | 1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9640 |
| Earnings Date | Nov 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Miravo Healthcare™ Announces Third Quarter 2022 Results
MISSISSAUGA, Ontario, November 14, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three and nine months ended September 30, 2022. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Fina
- Business Wire
Miravo Healthcare™ Announces Third Quarter 2022 Results Release Date and Conference Call Details
MISSISSAUGA, Ontario,, October 31, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2022 financial results before markets open on Monday, November 14, 2022.
- Business Wire
Miravo Healthcare™ Announces Appointment of Anthony Snow to its Board of Directors
MISSISSAUGA, Ontario, August 16, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the appointment of Anthony Snow to its Board of Directors (Board) on August 12, 2022.
